Article: Challenges in developing CAR T-cell therapies

Understand how quality control assays are being implemented in monitoring the development of CAR-T cells using high-throughput technologies in this article.

Read about the technological and clinical hurdles facing CAR T-cell therapies and their application to solid tumors. See how high-throughput assays provide a cost-effective route for the development of CAR-T cells, including topics on:


  • Tracking CAR T-cell responses with flow cytometry​​
  • Using ddPCR for CAR gene quality control​
  • Minimizing CAR T-cell therapy side effects​.